Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 162-165, January 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mochizuki, M.
Right arrow Articles by Okada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mochizuki, M.
Right arrow Articles by Okada, M.

Synthesis and Mutagenicity of 4-(N-Butylnitrosamino)-4-hydroxybutyric Acid Lactone, a Possible Activated Metabolite of the Proximate Bladder Carcinogen N-Butyl-N-(3-carboxypropyl)nitrosamine1

Masataka Mochizuki, Charles C. Irving, Takako Anjo, Yuko Wakabayashi, Emako Suzuki and Masashi Okada2

Tokyo Biochemical Research Institute, Takada 3-41-8, Toshima-ku, Tokyo 171, Japan, and Veterans Administration Hospital, Memphis, Tennessee 38104

4-(N-Butylnitrosamino)-4-hydroxybutyric acid lactone (BBAL) was synthesized as a possible intermediate produced by metabolic activation of a selective bladder carcinogen, N-butyl-N-(3-carboxypropyl)nitrosamine. BBAL was stable in neutral sodium phosphate buffer (ionic strength, 0.2), having a half-life of more than 30 hr at 25°. The mutagenic effects of BBAL were tested with the use of Salmonella typhimurium TA1535 and Escherichia coli B/rWP2-try-, WP2-try-hcr-, and Sd4. The gene-damaging effects were assayed by repair tests with Bacillus subtilis H17 (rec+) and M45 (rec-). BBAL showed potent effects in the mutation and repair tests on all the strains tested without activation. A possibility is suggested for the metabolic activation of N-butyl-N-(3-carboxypropyl)-nitrosamine to BBAL by {alpha}-hydroxylation at the site of the 3-carboxypropyl chain followed by lactonization in target tissues prior to interaction with macromolecules to lead to carcinogenesis.

1 Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan, by the U.S.-Japan Cooperative Cancer Research Program from the Japan Society for the Promotion of Science and by USPHS Research Grant CA16765 from the National Cancer Institute through the National Bladder Cancer Project. Presented at the 36th Annual Meeting of the Japanese Cancer Association, October 1977, Tokyo (14).

2 To whom requests for reprints should be addressed.

Received 5/29/79. Accepted 10/11/79.




This article has been cited by other articles:


Home page
MutagenesisHome page
Y. Mori, A. Koide, K. Fuwa, H. Wanibuchi, and S. Fukushima
Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53(+/-) knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
Mutagenesis, September 1, 2001; 16(5): 377 - 383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.